首页> 外国专利> USE OF HUMAN GROWTH HORMONE TO INCREASE THE NUMBER OF CIRCULATING CD34+ CELLS, INTENDED FOR RECONSTITUTION OF THE HEMATOPOIETIC AND IMMUNE SYSTEMS FOLLOWING MYELOABLATIVE OR ANTIBLASTIC THERAPIES, BY TRANSPLANTATION, RE-INFUSION OR ENGRAFTMENT

USE OF HUMAN GROWTH HORMONE TO INCREASE THE NUMBER OF CIRCULATING CD34+ CELLS, INTENDED FOR RECONSTITUTION OF THE HEMATOPOIETIC AND IMMUNE SYSTEMS FOLLOWING MYELOABLATIVE OR ANTIBLASTIC THERAPIES, BY TRANSPLANTATION, RE-INFUSION OR ENGRAFTMENT

机译：使用人类生长激素来增加循环的CD34 +细胞的数量，目的是通过移植，再注入或再移植，在造血或抗肿瘤治疗后重建造血和免疫系统

页面导航

摘要
著录项
相似文献

摘要

The invention relates to the field of hematopoietic CD34 + cell mobilization. In particular, this invention relates to a method for increasing the mobilization of pluripotent hematopoietic CD34 + cells by administration of human growth hormone or one of its derivates to the individual.

机译：本发明涉及造血CD34 +细胞动员领域。特别地，本发明涉及通过向人施用人生长激素或其一种衍生物来增加多能造血CD34 +细胞动员的方法。

著录项

公开/公告号SI1140149T1

专利类型
公开/公告日2007-02-28

原文格式PDF
申请/专利权人 APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.;
展开▼

申请/专利号SI19990030937T
发明设计人 GIANNI ALESSANDRO MASSIMO;
展开▼

申请日1999-12-30
分类号A61K38;A61K35;A61K35;A61K35/14;A61K35/28;A61K38;A61K38/22;A61K38/27;A61K39/395;A61P7;A61P7/06;A61P19/10;A61P35;A61P35/02;A61P37;C12N5;C12N5/06;C12N5/08;
国家 SI
入库时间 2022-08-21 20:56:29

相似文献

专利
外文文献
中文文献